Decreased Cardiac Expression of Vascular Endothelial Growth Factor and Its Receptors in Insulin-Resistant and Diabetic States
Eva Chou(Harvard University), George L. King(Joslin Diabetes Center), Chris J. Vlahos(Eli Lilly (United States)), Lloyd Paul Aiello(Joslin Diabetes Center), Izumi Suzuma(Joslin Diabetes Center), Nancy Bowling(Joslin Diabetes Center), Allen C. Clermont(Joslin Diabetes Center), Kiyoshi Suzuma(Joslin Diabetes Center), Darren M. Opland(Joslin Diabetes Center), Kerrie J. Way(Harvard University), Keiko Naruse(Aichi Gakuin University)
Cited by 338
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).
|Journal of Biological Chemistry|1994|3.3k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k